Professor of Medicine, Epidemiology & Biostatistics at UCSF
“Given the alternative, the Senate’s recommendation of a $400m increase for NIH is an indication the agency still has support on Capitol Hill,” says Jennifer Zeitzer of FASEB. “A 40% cut would have been devastating, so this is a good outcome in a tough year.”
“Given the alternative, the Senate’s recommendation of a $400m increase for NIH is an indication the agency still has support on Capitol Hill,” says Jennifer Zeitzer of FASEB. “A 40% cut would have been devastating, so this is a good outcome in a tough year.”